Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

17.10
-0.6700-3.77%
Post-market: 17.550.4500+2.63%19:30 EDT
Volume:1.40M
Turnover:24.25M
Market Cap:1.99B
PE:-13.07
High:17.83
Open:17.75
Low:17.01
Close:17.77
52wk High:21.45
52wk Low:9.82
Shares:116.45M
Float Shares:96.42M
Volume Ratio:0.81
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3082
EPS(LYR):-1.2221
ROE:-43.22%
ROA:-9.26%
PB:5.89
PE(LYR):-13.99

Loading ...

Novocure Ltd - Panova-4 Meets Primary Endpoint With Dcr of 74.4% VS 48% in Historical Control

THOMSON REUTERS
·
Mar 26

Should Japan’s Optune Lua Reimbursement Win Reframe NovoCure’s (NVCR) Access and Utilization Story?

Simply Wall St.
·
Mar 10

NovoCure (NVCR) Is Up 24.5% After FDA Approval Of Optune Pax And 2026 Guidance Update

Simply Wall St.
·
Mar 03

Japan approves national reimbursement for Novocure's Optune Lua in NSCLC

Reuters
·
Mar 02

Novocure Ltd - Optune Lua Approved for Use With Pd-1/Pd-L1 Inhibitors in Japan

THOMSON REUTERS
·
Mar 02

Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Mar 02

Novocure Ltd - to Launch Optune Lua in Japan With Reimbursement

THOMSON REUTERS
·
Mar 02

NovoCure Earnings Call: Growth Builds Amid Profit Strain

TIPRANKS
·
Mar 02

Novocure to Participate in Leerink Global Healthcare Conference

Reuters
·
Feb 28

Novocure Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 27

Novocure Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Stock Track | NovoCure Plunges 7.4% Pre-Market on Margin Pressure and Weak EBITDA Outlook

Stock Track
·
Feb 26

Earnings Flash (NVCR) Novocure Reports Q4 Loss $0.22 a Share, vs. FactSet Est of $0.41 Loss

MT Newswires Live
·
Feb 26

Novocure Q4 revenue slightly beats expectations, margins drop

Reuters
·
Feb 26

Novocure Q4 Revenue USD 174.35 Million Vs. IBES Estimate USD 173.4 Million

Reuters
·
Feb 26

Novocure Q4 net loss hits USD 24.5 million as R&D spending rises 19% to USD 60.9 million

Reuters
·
Feb 26

Novocure Q4 Pretax Profit USD -40.954 Million

THOMSON REUTERS
·
Feb 26

Novocure Ltd: Outlook 2026 Adj Ebitda $-20 Mln - $0 Mln

THOMSON REUTERS
·
Feb 26

Novocure Ltd - 2026 Revenue Guidance $675 Mln-$705 Mln

THOMSON REUTERS
·
Feb 26

Today’s Market Recap: AI Momentum Lifts U.S. Markets as Tariff Battles and Global Trade Tensions Unfold

TradingKey
·
Feb 26